These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4601632)

  • 1. Some speculations concerning a possible biochemical basis of minimal brain dysfunction.
    Wender PH
    Life Sci; 1974 May; 14(9):1605-21. PubMed ID: 4601632
    [No Abstract]   [Full Text] [Related]  

  • 2. Some speculations concerning a possible biochemical basis of minimal brain dysfunction.
    Wender PH
    Ann N Y Acad Sci; 1973 Feb; 205():18-28. PubMed ID: 4570233
    [No Abstract]   [Full Text] [Related]  

  • 3. The biochemical basis of minimal brain dysfunction.
    Shaywitz SE; Cohen DJ; Shaywitz BA
    J Pediatr; 1978 Feb; 92(2):179-87. PubMed ID: 340625
    [No Abstract]   [Full Text] [Related]  

  • 4. How amphetamine acts in minimal brain dysfunction.
    Snyder SH; Meyerhoff JL
    Ann N Y Acad Sci; 1973 Feb; 205():310-20. PubMed ID: 4570236
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Some speculations concerning a possible biochemical basis of minimal brain dysfunction.
    Wender PH
    Psychopharmacol Bull; 1974 Oct; 10(4):35-6. PubMed ID: 4471620
    [No Abstract]   [Full Text] [Related]  

  • 6. The minimal brain dysfunction syndrome in children. I. The syndrome and its relevance for psychiatry. II. A psychological and biochemical model for the syndrome.
    Wender PH
    J Nerv Ment Dis; 1972 Jul; 155(1):55-71. PubMed ID: 4402515
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential pathomechanisms of ADHD based on neurometabolite changes.
    Husarova V; Ondrejka I; Tonhajzerova I
    Neuro Endocrinol Lett; 2010; 31(4):438-45. PubMed ID: 20802444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of 5-hydroxyptamine in minimal brain dysfunction.
    Brase DA; Loh HH
    Life Sci; 1975 Apr; 16(7):1005-15. PubMed ID: 124375
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic approaches to the syndrome of minimal brain dysfunction.
    Omenn GS
    Ann N Y Acad Sci; 1973 Feb; 205():212-22. PubMed ID: 4571747
    [No Abstract]   [Full Text] [Related]  

  • 10. Animal models related to developmental disorders: theoretical and pharmacological analyses.
    Mailman RB; Lewis MH; Kilts CD
    Appl Res Ment Retard; 1981; 2(1):1-12. PubMed ID: 6171193
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic issues in the syndrome of minimal brain dysfunction.
    Omenn GS
    Semin Psychiatry; 1973 Feb; 5(1):5-17. PubMed ID: 4610759
    [No Abstract]   [Full Text] [Related]  

  • 12. [Minimal brain dysfunction--neurobiological approach].
    Hilakivi L; Hilakivi I
    Duodecim; 1986; 102(1):17-25. PubMed ID: 2868879
    [No Abstract]   [Full Text] [Related]  

  • 13. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
    Heal DJ; Cheetham SC; Smith SL
    Neuropharmacology; 2009 Dec; 57(7-8):608-18. PubMed ID: 19761781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
    Staller JA; Faraone SV
    Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs.
    Groves PM; Rebec GV
    Annu Rev Psychol; 1976; 27():91-127. PubMed ID: 773267
    [No Abstract]   [Full Text] [Related]  

  • 16. Child psychiatry--the continuing controversy. Minimal cerebral (brain) dysfunction--clinical fact or neurological fiction? The syndrome critically re-examined in the light of some hard neurological evidence.
    Becker RD
    Isr Ann Psychiatr Relat Discip; 1974 Jun; 12(2):87-106. PubMed ID: 4606334
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective effects of phenylethylamine on central catecholamines: a comparative study with amphetamine.
    Karoum F; Speciale SG; Chuang LW; Wyatt RJ
    J Pharmacol Exp Ther; 1982 Nov; 223(2):432-9. PubMed ID: 7131298
    [No Abstract]   [Full Text] [Related]  

  • 18. Catecholamines and neurologic diseases (second of two parts).
    Moskowitz MA; Wurtman RJ
    N Engl J Med; 1975 Aug; 293(7):332-8. PubMed ID: 125386
    [No Abstract]   [Full Text] [Related]  

  • 19. [Minimal brain dysfunction syndrome and its significance in adolescence].
    Lahti E; Louhimo T
    Duodecim; 1973; 89(10):742-8. PubMed ID: 4586649
    [No Abstract]   [Full Text] [Related]  

  • 20. The alpha(2C)-adrenergic receptor mediates hyperactivity of coloboma mice, a model of attention deficit hyperactivity disorder.
    Bruno KJ; Hess EJ
    Neurobiol Dis; 2006 Sep; 23(3):679-88. PubMed ID: 16839770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.